BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25464848)

  • 1. Sema3C promotes the survival and tumorigenicity of glioma stem cells through Rac1 activation.
    Man J; Shoemake J; Zhou W; Fang X; Wu Q; Rizzo A; Prayson R; Bao S; Rich JN; Yu JS
    Cell Rep; 2014 Dec; 9(5):1812-1826. PubMed ID: 25464848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RLIP76 is overexpressed in human glioblastomas and is required for proliferation, tumorigenesis and suppression of apoptosis.
    Wang Q; Wang JY; Zhang XP; Lv ZW; Fu D; Lu YC; Hu GH; Luo C; Chen JX
    Carcinogenesis; 2013 Apr; 34(4):916-26. PubMed ID: 23276796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
    Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine/paracrine sphingosine-1-phosphate fuels proliferative and stemness qualities of glioblastoma stem cells.
    Marfia G; Campanella R; Navone SE; Di Vito C; Riccitelli E; Hadi LA; Bornati A; de Rezende G; Giussani P; Tringali C; Viani P; Rampini P; Alessandri G; Parati E; Riboni L
    Glia; 2014 Dec; 62(12):1968-81. PubMed ID: 25042636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 promotes U87 glioblastoma stem cell migration and invasion.
    Chen X; Chen L; Chen J; Hu W; Gao H; Xie B; Wang X; Yin Z; Li S; Wang X
    Brain Res; 2013 Nov; 1538():151-8. PubMed ID: 23470260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma.
    Hao J; Han X; Huang H; Yu X; Fang J; Zhao J; Prayson RA; Bao S; Yu JS
    Nat Commun; 2023 Apr; 14(1):2262. PubMed ID: 37080989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
    Koyama-Nasu R; Haruta R; Nasu-Nishimura Y; Taniue K; Katou Y; Shirahige K; Todo T; Ino Y; Mukasa A; Saito N; Matsui M; Takahashi R; Hoshino-Okubo A; Sugano H; Manabe E; Funato K; Akiyama T
    Oncogene; 2014 Apr; 33(17):2236-44. PubMed ID: 23686309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
    Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
    Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.
    Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A
    Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1+ cells distributed in accordance with CD 133+ cells in glioblastomas and the elevated invasiveness of CD 133+ glioma cells with higher Rac1 activity.
    Zhang B; Sun J; Yu SP; Chen C; Liu B; Liu ZF; Ren BC; Ming HL; Yang XJ
    Chin Med J (Engl); 2012 Dec; 125(24):4344-8. PubMed ID: 23253699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
    Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
    Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models.
    Dermawan JK; Hitomi M; Silver DJ; Wu Q; Sandlesh P; Sloan AE; Purmal AA; Gurova KV; Rich JN; Lathia JD; Stark GR; Venere M
    Cancer Res; 2016 Apr; 76(8):2432-42. PubMed ID: 26921329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells.
    Sullivan KE; Rojas K; Cerione RA; Nakano I; Wilson KF
    Oncotarget; 2017 Apr; 8(14):22325-22343. PubMed ID: 28423611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small GTPase Rac1 is involved in the maintenance of stemness and malignancies in glioma stem-like cells.
    Yoon CH; Hyun KH; Kim RK; Lee H; Lim EJ; Chung HY; An S; Park MJ; Suh Y; Kim MJ; Lee SJ
    FEBS Lett; 2011 Jul; 585(14):2331-8. PubMed ID: 21704033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
    Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
    Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation.
    Morelli MB; Nabissi M; Amantini C; Farfariello V; Ricci-Vitiani L; di Martino S; Pallini R; Larocca LM; Caprodossi S; Santoni M; De Maria R; Santoni G
    Int J Cancer; 2012 Oct; 131(7):E1067-77. PubMed ID: 22492283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
    Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
    Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
    Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
    J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.